Evidence map›Paper›PMID 31426384›Full record

ArticleMicroorganisms2019

Unveiling of Concealed Processes for the Degradation of Pharmaceutical Compounds by

Bo Ram Kang, Min Sung Kim, Tae Kwon Lee

Abstract read
In one paragraph

Article in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Frontiers in cellular and infection microbiology · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bo Ram KangDepartment of Environmental Engineering, Yonsei University, Wonju 26493, Korea.
Min Sung KimDepartment of Environmental Engineering, Yonsei University, Wonju 26493, Korea.
Tae Kwon LeeDepartment of Environmental Engineering, Yonsei University, Wonju 26493, Korea. tklee@yonsei.ac.kr.ORCID 0000-0003-3845-7316

Funding

National Research Foundation of Korea 2017R1D1A3B03029787
6 · The paper itself

Abstract

The presence of pharmaceutical products has raised emerging biorisks in aquatic environments. Fungi have been considered in sustainable approaches for the degradation of pharmaceutical compounds from aquatic environments. Soft rot fungi of the Ascomycota phylum are the most widely distributed among fungi, but their ability to biodegrade pharmaceuticals has not been studied as much as that of white rot fungi of the Basidiomycota phylum. Herein, we evaluated the capacity of the soft rot fungus

Indexed as

Ascomycotabiodegradationextracellular enzymesNeopestalotiopsispharmaceutical compounds

Identifiers

PMID31426384
PMCPMC6722755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.